Análisis preliminar in silico de azitromicina con proteínas humanas relacionadas al SARS-CoV-2
- PMID: 32876237
- DOI: 10.17843/rpmesp.2020.372.5465
Análisis preliminar in silico de azitromicina con proteínas humanas relacionadas al SARS-CoV-2
Comment on
-
RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20. Int J Antimicrob Agents. 2020. Retraction in: Int J Antimicrob Agents. 2025 Jan;65(1):107416. doi: 10.1016/j.ijantimicag.2024.107416. PMID: 32205204 Free PMC article. Retracted. Clinical Trial.
Similar articles
-
Hydroxychloroquine and azithromycin as a treatment of COVID-19.Intern Emerg Med. 2020 Aug;15(5):841-843. doi: 10.1007/s11739-020-02388-y. Epub 2020 May 30. Intern Emerg Med. 2020. PMID: 32474851 Free PMC article. No abstract available.
-
Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend.J Infect. 2020 Aug;81(2):e117-e119. doi: 10.1016/j.jinf.2020.05.058. Epub 2020 May 28. J Infect. 2020. PMID: 32474031 Free PMC article. No abstract available.
-
Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going.J Glob Antimicrob Resist. 2020 Sep;22:680-684. doi: 10.1016/j.jgar.2020.06.016. Epub 2020 Jul 1. J Glob Antimicrob Resist. 2020. PMID: 32622008 Free PMC article.
-
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.CMAJ. 2020 Apr 27;192(17):E450-E453. doi: 10.1503/cmaj.200528. Epub 2020 Apr 8. CMAJ. 2020. PMID: 32269021 Free PMC article. Review. No abstract available.
-
Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?Front Immunol. 2020 Aug 7;11:1969. doi: 10.3389/fimmu.2020.01969. eCollection 2020. Front Immunol. 2020. PMID: 32849658 Free PMC article. Review.